Back to search

Article

Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific risk

2019-04-12

Abstract excerpt

<h4>Background</h4> Commercial gene expression signatures of prostate cancer (PCa) prognosis were developed and validated in cohorts of predominantly European American men (EAM). Limited research exists on the value of such signatures in African American men (AAM), who have poor PCa outcomes. We explored differences in gene expression between EAM and AAM for three commercially available panels recommended by the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03e716bd-89fb-5ff9-9916-5f5f7c977005
DOI
10.1101/604058
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific riskDOI 10.1101/604058
Select a neighboring publication to make it the new centre.